FDA Panel Gives Nod to Blood Test for Colon Cancer

A U.S. Food and Drug Administration advisory panel on Thursday recommended the approval of a new blood test that can spot colon cancer.

The panel voted 7-2 that the benefits outweigh the risks when using the Guardant Health’s Shield test for colon cancer.

Source: Advances and More licensed by HealthDay